Table 1 Characteristics of subjects (N = 243) included in the study
N (%) | |
|---|---|
Sex (N) | |
Male | 140 (57.6) |
Female | 103 (42.4) |
Comorbidities (N) | |
Any | 206 (84.8) |
Hypertension | 181 (74.5) |
Diabetes mellitus | 129 (53.1) |
Chronic kidney disease | 73 (15.2) |
COPD | 15 (6.2) |
Oncological disease | 10 (4.1) |
Dementia | 6 (2.5) |
Autoimmune disease | 3 (1.2) |
Liver disease | 2 (0.8) |
Age (years) | |
60–65 | 59 (24.3) |
66–70 | 59 (24.3) |
71–75 | 55 (22.6) |
≥ 76 | 70 (28.8) |
Charlson Comorbidity Index (N) | |
Mild 1–2 | 50 (20.6) |
Moderate 3–4 | 113 (46.5) |
Severe ≥ 5 | 80 (32.9) |
Outcome (N) | |
Death | 145 (59.7) |
Recovery | 98 (40.3) |
ABC-GOALScl (N) | |
0–3 Low risk | 12 (4.9) |
5–9 Moderate risk | 148 (60.9) |
≥ 10 High risk | 83 (34.2) |
Mean (Min, Max) | |
Days of hospitalization | 11.53 (1, 110) |
Total comorbidities (N) | 1.6 (0, 4) |
BMI | 28.7 (16.7, 59.03) |
Systolic arterial pressure (mmHg) | 130.7 (52, 220) |
Respiratory frequency (breaths/min) | 25.5 (12, 48) |
O2 saturation (sO2) | 0.8 (0.15, 0.99) |
fraction of inspired oxygen (FiO2) | 0.4 (0.21, 1.00) |
sO2/FiO2 ratio | 294.8 (18.75, 466.67) |
Laboratory results | |
Glucose (mg/dL) | 190.8 (32, 1097) |
Albumin (g/dL) | 3.2 (1.38, 4.34) |
LDH (U/L) | 411 (110, 2950) |